Singulair - News Articles

TradersHuddle.com - Merck Close to the 50 Day | Trading Ideas


Propecia for treatment for male pattern hair loss, Fosamax for preventive treatment of osteoporosis, and Singulair for treatment of asthma. Merck was founded in 1891 and is headquartered in Whitehouse Station, New Jersey. Looking at peaks and troughs ...
Many more people not getting their medications, study finds | Booster Shots | Los Angeles Times


The top 10 brand-name drugs in 2009 were Lipitor, Nexium, Plavix, Singulair, Synthroid, Lexapro, ProAir HFA, Crestor, Advair Diskus and Diovan. Sales of Lipitor were down 11.7%. The only gainers among the group were Plavix (3.9%), Proair HFA (56%), Crestor ...
Gerçek Gündem: Türkiye'nin ihtiyaci...


Bunlar; kortizonlu spreyler, montelukast gibi çigneme tabletleri veya kromolin içeren ilaçlardir. Bu ilaçlarin uzun süreli tedavisi, mutlak doktor kontrolünde yapilmalidir. Bir diger tedavi asi tedavisidir. Bu tedavi, koruyucu yöntemler ve ilaç tedavisi ile düzelmeyen, bazi seçilmis grupta ...
Montelukast?????????????????-????-??????


?24drs.com?March 10, 2010(???)-??????????,????????(RSV)???????????,??montelukast(Singular,????)????, ?????????????,?????????? ????????Inje??Paik???????????????Hyo-Bin Kim????????????????(AAAAI)2010???????????,?????????,????????????????????;????????? Kim????,?????????????????????????????????????????? ?EDN???????? ...
How to Treat Kids' Hard-to-Control Asthma


About 30% of kids, the study found, do best either with a leukotriene-receptor antagonist (LTRA, brands include Accolate, Singulair, and Zyflo) or by ...
Dysport Takes On Botox With Aggressive Rebates - NYTimes.com


Another Merck ad carries a $20 coupon for the allergy and asthma drug Singulair. But it is vanity medicine — including products like Botox and Dysport — that has been at the forefront of consumer enticement programs. That is because insurance typically does not cover ...
Study Finds Lack of Asthma Controller Medications Contributed to Out-of-Hospital Deaths | News | RT: For Decision Makers in Respiratory Care


Ten of the patients had been using other asthma medications, including six on oral steroids, three on montelukast, and one on omalizumab. Stanley Szefler, MD, of National Jewish Health and the University of Colorado in Denver, who was not ...
Health & Medical Breakthroughs News - Long-Acting Beta-Agonists Shown to be Most Effective Step-Up Therapy for Children with Poorly Controlled Asthma

MedPage Today
African-Americans were equally likely to respond best to LABA step-up or corticosteroid step-up, but not the montelukast. The addition of LABA step-up therapy was most likely to give the best response to white patients, with inhaled corticosteroid step-up the least favorable. ...
?j????


?????,???????????????????,????????????,???????????????(Montelukast sodium)????????? ...
AAP Grand Rounds -- Sign In Page


After stabilization, patients were randomized to receive prednisone/prednisolone or montelukast in appropriate age-related doses at 24, 48, 72, 96, ...
Queensbury woman testifies before FDA panel


Miller's 15-year-old son, Cody, committed suicide in August 2007, 17 days after being on the allergy medication Singulair. Depression had been added as a possible side effect of the drug in April 2007, but there was no public notification of the finding, said ...
Merck Oral Allergy Immunotherapy Treatment Reduces Symptoms - WSJ.com


after the pharmaceutical giant recently emerged from patent battles leaving its best-selling Singulair free of generic competition until 2012. ...
Leading Patient Education Group Provides Straight Answers to FDA’s Announcement about Asthma Medications


I suggest they contact their clinician and discuss weaning down to the lowest dose of inhaled corticosteroids or using a leukotriene modifiers (Singulair ® , Accolate ®and Zyflo ®) while carefully avoiding known allergens and irritants and see how they do." Asthma is ...
New Drugs for Allergies | EmpowHER - Women's Health Online


Montelukast (brand name Singulair) is already approved for allergies as well as asthma. This is a once-a-day pill. A recent medical article reports that it improves quality of life for most patients, either alone or in combination with antihistamines. Side effects include gastrointestinal symptoms, ...
GSK Statement on FDA's Proposed Label Revisions for Some Asthma Medicines | Press Releases @ Your Story


in asthma-related hospitalizations and emergency department visits in children receiving Advair versus ICS alone and versus ICS plus montelukast. As with all medications, the decision to stop or change any therapy should be discussed with a ...
UPDATE: US Patent Office Tentatively Rejects Plavix Claims - WSJ.com


(MRK)--the PTO tentatively rejected claims in Merck's patent for asthma drug Singulair during a re-exam, but then upheld the claims in December and ...
Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma - News Press Release | PharmiWeb.com


have successfully worked together for more than a decade and were pivotal in the discovery of a number of inflammatory drugs, including Singulair(R). The drug hunters at Amira are now actively leveraging their history of success to create high-value compounds for the ...
7 Drug Stocks to Buy Now - Kiplinger.com


With more than a dozen drugs in late-stage development, Merck should easily be able to offset losses from big sellers, such as Singulair, an asthma drug that goes generic in 2012. Schering also has several biotech drugs in the works, including a new fertility treatment. ...
Über die Asthma-Therapie entscheidet jetzt die Krankheitskontrolle


Die Kombination ICS / LABA sei wirksamer oder besser verträglich als die Alternativen ICS plus Montelukast und ICS plus Theophyllin. Sind die Patienten unter einer Kombinationstherapie mit Controller-Substanzen mindestens drei Monate beschwerdefrei, kann eine Deeskalation der Therapie ...
Amira Mixes Small Biotech Irreverence, With Big Pharma Rigor, To Create New Lung Drugs | Xconomy


As I described in a feature last March, they played important roles in developing montelukast sodium (Singulair), the asthma drug that generates $4 billion a year in revenue, and they resolved to try to do it again at their own company in San ...

Pages:   1   2   3   4   5   6   ...   Next

AddThis Social Bookmark Button

Need A Singulair Attorney?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


Need A Singulair Lawyer?

First Name Last Name Email Address State
Was Your Health Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Singulair Case - Submit Your Information Below

Do you need legal assistance with your Singulair case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * Unsafe Drugs: Singulair Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.